Related Experiment Videos
PUVA treatment in Sweden
1Department of Dermatology, Karolinska Sjukhuset, Stockholm, Sweden.
Acta Dermato-Venereologica. Supplementum
|January 1, 1991
Summary
This study analyzed PUVA treatment patterns in Sweden from 1974-1985, revealing Psoriasis as the primary indication. Oral 8-MOP was the dominant psoralen regimen, with whole-body treatment being most common.
Area of Science:
- Dermatology
- Phototherapy
- Medical Informatics
Background:
- PUVA (psoralen plus ultraviolet A) therapy is a recognized treatment for various skin conditions.
- Understanding historical treatment patterns is crucial for evaluating long-term efficacy and safety.
- Sweden has a centralized healthcare system, facilitating multi-center data collection.
Purpose of the Study:
- To delineate the utilization and protocols of PUVA therapy across Swedish centers between 1974 and 1985.
- To identify the most frequent dermatological indications for PUVA treatment.
- To analyze variations in psoralen regimens, treatment areas, and cumulative dosages.
Main Methods:
- A retrospective analysis of 4945 patient records from eleven Swedish centers.
- Data collected between 1974 and 1985, encompassing treatment protocols and patient demographics.
- Computerized evaluation of collected information for pattern identification.
Main Results:
- Psoriasis (64%), Pustulosis Palmo Plantaris (10.5%), and Eczema (9.4%) were the leading indications.
- Oral 8-MOP was the predominant psoralen (77.1%), with whole-body treatment being most frequent (70.6%).
- Significant variations in treatment frequency and cumulative dosage were observed, with some patients receiving extensive treatment.
Conclusions:
- PUVA therapy was widely applied in Sweden during the study period, primarily for Psoriasis.
- Oral 8-MOP and whole-body application characterized the dominant treatment approach.
- The data highlights considerable variation in treatment intensity, necessitating further investigation into dose-response relationships and long-term outcomes.